Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Yoshiharu Sada is active.

Publication


Featured researches published by Yoshiharu Sada.


Clinical and Experimental Hypertension | 2013

Characteristics of patients with severe heart failure exhibiting exercise oscillatory ventilation.

Ryosuke Matsuki; Tomohiko Kisaka; Ryoji Ozono; Hiroki Kinoshita; Yoshiharu Sada; Noboru Oda; Takayuki Hidaka; Naonori Tashiro; Makoto Takahashi; Kiyokazu Sekikawa; Yoshihiro Ito; Hiroaki Kimura; Hironobu Hamada; Yasuki Kihara

This study aims to elucidate the characteristics of patients with severe nonischemic heart failure exhibiting exercise oscillatory ventilation (EOV) and the association of these characteristics with the subjective dyspnea. Forty-six patients with nonischemic heart failure who were classified into the New York Heart Association (NYHA) functional class III underwent cardiopulmonary exercise testing (CPX) and were divided into two groups according to the presence or absence of EOV. We evaluated the patients by using the Specific Activity Scale (SAS), biochemical examination, echocardiographic evaluation, results of CPX and symptoms during CPX (Borg scale), and reasons for exercise termination. EOV was observed in 20 of 46 patients. The following characteristics were observed in patients with EOV as compared with those without EOV with statistically significant differences: more patients complaining dyspnea as the reason for exercise termination, lower SAS score, higher N-terminal pro-brain natriuretic peptide level, larger left atrial dimension and volume, left ventricular end-diastolic volume, higher Borg scale score at rest and at the anerobic threshold, higher respiratory rate at rest and at peak exercise, and higher slope of the minute ventilation-to-CO2 output ratio, and lower end-tidal CO2 pressure at peak exercise. Among the subjects with NYHA III nonischemic heart failure, more patients with EOV had a stronger feeling of dyspnea during exercise as compared with those without EOV, and the subjective dyspnea was an exercise-limiting factor in many cases.


Circulation | 2016

Prognostic Factors for Survival in Pulmonary Hypertension Due to Left Heart Disease

Sayuri Yamabe; Yoshihiro Dohi; Shinya Fujisaki; Akifumi Higashi; Hiroki Kinoshita; Yoshiharu Sada; Takayuki Hidaka; Satoshi Kurisu; Hideya Yamamoto; Yasuki Kihara

BACKGROUND The epidemiological data of pulmonary hypertension (PH) due to left heart disease (LHD) are limited. This study investigated hemodynamic and clinical factors associated with mortality in patients with PH due to LHD. METHODS AND RESULTS We conducted a retrospective review in 243 patients with PH due to LHD, defined as mean pulmonary arterial pressure ≥25 mmHg and pulmonary wedge pressure >15 mmHg at rest in right heart catheterization. Kaplan-Meier and Cox proportional hazard regression analyses were performed. Seventy-five patients died during an average follow-up of 52 months (range, 20-73 months). On multivariate analysis, only diastolic pulmonary vascular pressure gradient (DPG) ≥7 mmHg among hemodynamic measurements was a predictor of mortality. Elevated N-terminal pro-brain natriuretic peptide (NT-pro BNP), more severe New York Heart Association (NYHA) class, anemia, and renal dysfunction were more strongly associated with mortality. Mean right atrial pressure (RAP) and currently available markers of pulmonary vascular remodeling including transpulmonary pressure gradient (TPG) and pulmonary vascular resistance (PVR) had no effect on survival. CONCLUSIONS DPG is weakly associated with mortality in PH due to LHD. Clinical factors such as NT-pro BNP, NYHA class, anemia and renal dysfunction are superior predictors. The prognostic ability of hemodynamic factors such as mean RAP, TPG, PVR and DPG is limited.


Internal Medicine | 2015

The Potential Role of Inflammation Associated with Interaction between Osteopontin and CD44 in a Case of Pulmonary Tumor Thrombotic Microangiopathy Caused by Breast Cancer.

Akifumi Higashi; Yoshihiro Dohi; Naohiro Uraoka; Kazuhiro Sentani; Sayuri Uga; Hiroki Kinoshita; Yoshiharu Sada; Toshiro Kitagawa; Takayuki Hidaka; Satoshi Kurisu; Hideya Yamamoto; Wataru Yasui; Yasuki Kihara

Pulmonary tumor thrombotic microangiopathy (PTTM) is a rare and fatal cancer-related complication. We herein present a case of PTTM that diagnosed antemortem by lung scintigraphy and pulmonary microvascular cytology. The patient was treated with steroid pulse therapy. Although her symptoms temporarily improved, she died of respiratory failure. An autopsy showed PTTM, and an immunohistochemical analysis revealed the expression of osteopontin and CD44 in macrophages that had migrated into the PTTM lesions. These findings suggest that inflammation associated with the interaction between osteopontin and CD44 may play an important role in PTTM.


Heart and Vessels | 2016

Non-suppressive regulatory T cell subset expansion in pulmonary arterial hypertension

Yoshiharu Sada; Yoshihiro Dohi; Sayuri Uga; Akifumi Higashi; Hiroki Kinoshita; Yasuki Kihara


Heart and Vessels | 2016

Clinical value of regression of electrocardiographic left ventricular hypertrophy after aortic valve replacement

Sayuri Yamabe; Yoshihiro Dohi; Akifumi Higashi; Hiroki Kinoshita; Yoshiharu Sada; Takayuki Hidaka; Satoshi Kurisu; Nobuo Shiode; Yasuki Kihara; Hero Investigators


Heart and Vessels | 2017

Evaluation of end-tidal CO2 pressure at the anaerobic threshold for detecting and assessing pulmonary hypertension

Akifumi Higashi; Yoshihiro Dohi; Sayuri Yamabe; Hiroki Kinoshita; Yoshiharu Sada; Toshiro Kitagawa; Takayuki Hidaka; Satoshi Kurisu; Hideya Yamamoto; Yuji Yasunobu; Yasuki Kihara


Journal of Cardiac Failure | 2015

Prognositic Value of Oscillatory Ventilation during Rest and Exercise in Patients with Heart Failure

Hiroki Kinoshita; Yoshihiro Dohi; Yoshiharu Sada; Tomohiko Kisaka; Toshiro Kotagawa; Takayuki Hidaka; Hideya Yamamoto; Yasuki Kihara


Journal of Cardiac Failure | 2015

Prognostic Factors for Survival in Patients with Pulmonary Hypertension Due to Left Heart Disease

Sayuri Uga; Akifumi Higashi; Hiroki Kinoshita; Yoshiharu Sada; Yoshihiro Dohi; Yasuki Kihara


Journal of Cardiology Cases | 2014

Cooperation between Heart Failure Center of Hiroshima University Hospital and a regional medical facility: Option for an end-of-life heart failure patient receiving palliative care

Tomohiko Kisaka; Yoshiharu Sada; Natsumi Takeuchi; Mariko Mizukawa; Noboru Oda; Hiroaki Kimura; Yasuki Kihara


Journal of Cardiac Failure | 2014

Multicenter Survey on Health-care Costs for Hospitalization of Provisional Heart failure Patients Based on Elevated BNP Levels in Hiroshima Prefecture

Toshiro Kitagawa; Hiroki Kinoshita; Yoshiharu Sada; Mariko Mizukawa; Makiko Naka; Yasuki Kihara

Collaboration


Dive into the Yoshiharu Sada's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge